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Abstract
Obesity is a complex disease with multiple well-defined risk factors. Nevertheless, susceptibility to obesity and its
sequelae within obesogenic environments varies greatly from one person to the next, suggesting a role for gene ×
environment interactions in the etiology of the disorder. Epigenetic regulation of the human genome provides a
putative mechanism by which specific environmental exposures convey risk for obesity and other human diseases
and is one possible mechanism that underlies the gene × environment/treatment interactions observed in epide-
miological studies and clinical trials. A study published in BMC Medicine this month by Wang et al. reports on an
examination of DNA methylation in peripheral blood leukocytes of lean and obese adolescents, comparing methy-
lation patterns between the two groups. The authors identified two genes that were differentially methylated, both
of which have roles in immune function. Here we overview the findings from this study in the context of those
emerging from other recent genetic and epigenetic studies, discuss the strengths and weaknesses of the study
and speculate on the future of epigenetics in chronic disease research.
See research article: http://www.biomedcentral.com/1741-7015/8/87/abstract
Introduction
Obesity is highly prevalent in most industrialized
nations where labor-saving devices and calorically dense
diets are common [1]. The impressive results from ran-
domized clinical trials of intensive lifestyle modification
on short- to medium-term weight loss [2,3] give us
good reason to believe that traditional hunter-gatherer
or subsistence farming lifestyles might be a panacea for
the obesity epidemic. However, programs of lifestyle
modification are notoriously difficult to implement and
maintain on a large scale for prolonged durations, and
t h ep u b l i ch e a l t hm e s s a g eo f“eat less and exercise
more” appears to have fallen on deaf ears. Thus, despite
the apparently simple explanation and remedy for obe-
sity, this knowledge is not enough. So we are saddled
with a challenge, which is to unravel the mechanisms by
which obesity emerges and to understand how its pre-
sence causes disease and death, with the hope that
somewhere within the details hides the solution to the
problem.
Although obesity is widespread, certain ethnic groups
appear much more susceptible than others to the condi-
tion [4]. Striking differences in the rates of obesity are
often seen between genetically distinct subpopulations,
such as American Indians and people of northern Eur-
opean ancestry living within comparable environments,
indicating that obesity may be the consequence of gene
× environment interactions. More concrete evidence of
such interactions has emerged from epidemiological
cohort studies, most notably for the interaction between
a polymorphism at the FTO (fat mass and obesity gene)
locus and physical activity levels [5]. Nevertheless, even
where rare examples of statistically reliable gene ×
environment interactions have emerged from epidemio-
logical studies, causal inference is often difficult and lit-
tle is revealed about the underlying mechanisms driving
the interaction.
Mechanisms of gene × environment interactions
in disease
So what mechanisms might underlie the gene × envir-
onment interactions observed in epidemiological studies
or clinical trials? Clearly, the manner in which an inter-
action is defined and quantified will affect our ability to
understand the cellular mechanisms which underlie it.
However, assuming the interaction is a consequence of
environmental effects (for example, smoking, physical
activity, or dietary whole grains intake) on a disease trait
that are dependent on the genotype of an individual,
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isms that might give rise to the interaction (Figure 1).
The first involves differential transcription rates across
genotypes in response to environmental stimuli. During
aerobic exercise, as an example, subsets of genes, parti-
cularly those involved in oxidative energy metabolism,
are upregulated [6]. If the rates of transcription or trans-
lation of these genes were to differ by genotype, one
might, at a population level, observe a gene × lifestyle
interaction on a clinical phenotype such as blood glu-
cose concentrations. The second mechanism by which
genes and environmental factors might interact involves
epigenetic factors, such as DNA methylation and histone
modifications.
The word epigenetics describes the phenomena of
inherited changes in gene function that occur indepen-
dently of changes in the nucleotide sequence [7]. Initi-
a l l y ,i tw a sb e l i e v e dt h a te p i genetic modifications were
unidirectional, but recent studies have demonstrated
that the epigenome is in fact highly dynamic, changing
in response to nutrient availability, physical exercise and
aging, among other exposures [8-22]. While nearly all
cells in the body have the same nuclear genome, differ-
ent cell types have their own epigenomes, a characteris-
tic essential for the development of cell-specific
phenotypes. In differentiated mammalian cells,
DNA methylation occurs primarily to cytosines in CpG-
dinucleotides[23]. DNA methylation of gene promoters
has also been implicated in transcriptional silencing,
mainly through repressed transcription factor binding to
gene promoters or by recruiting methyl-CG-binding
proteins, which in turn recruit histone deacetyltrans-
ferases (HDACs) and corepressors. By virtue of the cell’s
capacity for histone modification, it can control its chro-
matin structure and either activate or suppress the tran-
scription of its genes. Early-life nutrition represents an
intriguing example of how environmentally augmented
epigenetic events might affect an individual’sr e s p o n s e
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Figure 1 The mechanisms that underlie observations of gene × environment interactions made in epidemiological studies (or gene ×
treatment interactions in clinical trials) likely involve a combination of epigenetic and transcriptional modifications. Although
environmental exposures may be the primary triggers of these perturbations, the phenotypes themselves may also feed back to trigger both
epigenetic and transcriptomic events, thus modulating the expression of disease phenotypes. The figure shows a simplification of how these
processes might fit together. HDAC, histone deacetyltransferase; NCor, nuclear receptor corepressor; MeCP2, methyl CpG binding protein 2.
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hood, with numerous studies lending weight to this
hypothesis [14-16,24,25]. Nevertheless, our understand-
ing of how epigenetic events early in life influence the
development of obesity and its comorbidities remains
fairly rudimentary.
This month in BMC Medicine, Wang et al. [26] report
a study in which they examined DNA methylation in
isolated blood leukocytes and its relationship with obe-
sity-induced immune dysfunction in seven lean and
seven obese African American male adolescents. Specifi-
cally, the authors examined DNA methylation in periph-
eral blood leukocytes at approximately 27,000 CpG sites
spread across more than 14,000 genes and compared
methylation patterns between the two groups. Epigenetic
studies are often constrained in their size by the high
costs of the methylation chips (although this obstacle is
receding as the technology becomes less expensive).
This, in combination with the multitude of hypothesis
tests that are performed in multiplex experiments and
the corresponding procedures to correct for type 1
errors, render almost all existing epigenetic studies
underpowered to detect statistically robust effects. Such
is the case with the study conducted by Wang et al.;
indeed, none of the findings from the first phase of their
experiment remained statistically significant after correc-
tion for multiple testing. Despite this, the authors car-
ried forward their most promising findings (defined as
either genes yielding association P values ≤2×1 0
-4 or
those with differences in DNA methylation ≥27.1%) for
replication in a cohort composed of 45 obese and 46
lean individuals. In these replication analyses, two of six
genes were differentially methylated in obese compared
with lean individuals; the levels of DNA methylation for
UBASH3A (ubiquitin-associated and SH3 domain-
containing A) and TRIM3 (tripartite motif-containing 3)
were higher and lower, respectively, in obese compared
with lean individuals, findings that were directionally
consistent with those from the first phase of the study.
Interestingly, recent genome-wide scans have impli-
cated DNA variants proximal to UBASH3A,w h i c h
encodes a T-cell signaling- and activation-regulating
protein [27], in the development of type 1 diabetes [28].
Thus, the findings of Wang et al.,w h e np l a c e di nc o n -
text with existing genetic data, suggest that UBASH3A
may play a role in obesity-induced immune dysfunction.
Intriguingly, TRIM3,w h i c hb e l o n g st ot h es u p e r f a m i l y
of TRIM proteins, is also involved in immune response
[29], which may explain why differential methylation
patterns of these genes were visible in blood leukocytes.
The study by Wang et al. is small and probably
underpowered to detect all but the largest differences in
DNA methylation. It may be, therefore, that with a lar-
ger sample size, statistically significant differences in
DNA methylation patterns for many other genes that
are smaller in magnitude than for UBASH3A and
TRIM1 would be observable. The detection of other
CpG sites and genes might also be facilitated by the
application of methods that afford greater genomic cov-
erage, such as deep sequencing combined with either
bisulfite-treated DNA or immunoprecipitation of methy-
lated DNA.
While peripheral blood leukocytes are attractive for
epigenetic studies, not least because they can be easily
obtained, there are many other cell types and tissues
involved in the pathogenesis of obesity and its comor-
bidities, such as adipose tissue, skeletal muscle and
hypothalamus, the examination of which could be well
worthwhile in the context of epigenetics. Along these
lines, Bouchard et al. [17] recently provided some of the
first evidence that DNA methylation in adipose tissue
differs in people who respond well and those who
respond poorly to caloric restriction for weight loss.
Elsewhere, a high-fat diet lasting 5 days was shown to
affect DNA methylation of a major transcriptional coac-
tivator (peroxisome proliferator-activated receptor-g
coactivator 1-a) of genes involved in oxidative energy
metabolism [13]. Furthermore, in studies examining
early life overnutrition and obesity, DNA methylation of
the hyperthalamically expressed pro-opiomelanocortin
promoter, which plays an important role in hunger and
satiation [30], was observed. While these studies imply
that epigenetic modifications cause obesity, metabolic
disease and its complications, it is virtually impossible to
establish whether changes in methylation precede the
development of obesity or vice versa. Indeed, these rela-
tionships may not be causal at all, but consequences of
confounding by factors correlated with obesity and
DNA methylation, such as physical inactivity, nutrition
or smoking.
Elucidating causal relationships between DNA methy-
lation and obesity will be necessary if observations of
the nature described by Wang et al. are to be of clinical
value. Inevitably, this probably means that randomized,
controlled trials of weight loss or weight gain interven-
tions, where DNA methylation patterns are assessed
before and after the intervention and subsequently com-
pared between the treatment and control arms of the
trial, are required. It will also be necessary to examine
whether changes in DNA methylation correspond with
changes in gene transcription and/or translation, as well
as more distal, clinically relevant phenotypes. Assessing
these relationships in diverse tissues and cell types and
in different demographic groups and environmental
contexts will further advance our understanding of how
epigenetic events affect an individual’s predisposition to
obesity, or how obesity impacts the epigenome. Whether
changes in DNA methylation are associated with
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(that is, whether DNA methylation coincides with the
presence of closed histone marks) represents another
interesting but as yet unanswered question.
Concluding remarks
In summary, Wang et al.’s study provides tentative evi-
dence that DNA methylation at two loci, UBASH3A and
TRIM3, may be implicated in the pathogenesis of obe-
sity. Replication of these findings in independent set-
tings will be necessary to ensure that these findings are
true positives, and to fairly conclude that the relation-
ships are causal will require appropriately designed
experimental studies. Because of these and other hurdles
facing the field of epigenetics, identifying a meaningful
clinical application for epigenetics in the prevention or
treatment of obesity is likely to remain more vision than
reality for some time to come.
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